´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium : 2022-05-14±³À°ÀÏÀÚ : 2022-05-14
±³À°Àå¼Ò : ¿Â¶óÀÎ °³ÃÖ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ Áغñ»ç¹«±¹
¿¬¶ôó : 02-373-1005
À̸ÞÀÏ :
kaslsecretariat@hbni.co.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í »çÀüµî·Ï-ȸ¿ø, ÀüÀÓÀÇ, Àü°øÀÇ 30,000¿ø / ºñȸ¿ø, ¿Â¶óÀΠȸ¿ø 40,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 10:10~10:35 Conventional and New Biomarkers for the Management of Chronic Hepatitis B Virus Infection Marc G. Ghany(National Institute of Health, USA)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 10:35~11:00 Clinical Features of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Chronic Liver Disease Ju Dong Yang(Cedars-Sinai Medical Center, USA)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:00~11:25 Novel Biomarkers for Renal Outcomes in Patients with Liver Cirrhosis Jasmohan S. Bajaj(Virginia Commonwealth Univ., USA)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:25~11:50 Glycemic Control and Non-Alcoholic Fatty Liver Disease Prognosis Manal F. Abdelmalek(Duke Univ. Medical Center, USA)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:00~13:20 Epidemiology and Natural History of Autoimmune Liver Diseases Á¤¼÷Çâ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:20~13:40 Pathogenesis of Autoimmune Liver Diseases: Genetics and Environmental Factors Áø¿µÁÖ(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:40~14:00 Autoimmune Liver Diseases after Viral Infections Including COVID-19 and Vaccines ±è°æ¾Æ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:00~14:20 How Do Drugs Trigger Autoimmune Liver Injury?: Immune Checkpoint Inhibitors and Biological Agents À¯¼öÁ¾(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:40~15:00 Diagnosis of Autoimmune Hepatitis and Overlap Syndrome ¹ÚÁ¤±æ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:00~15:20 Differential Pathologic Features between AIH, PBC and PSC ÀÌÇý¿ø(°è¸íÀÇ´ë)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:20~15:40 Standard and Emerging Treatments of Autoimmune Liver Disease ¹Ú¼ö¿µ(°æºÏÀÇ´ë)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:40~16:00 Rescue Therapies for Relapsing and Difficult-To-Treat Autoimmune Liver Disease ¼ÛÁ¤Àº(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 12:30~13:00 ÃÊÀ½ÆÄ ±â±â ¼¼Æà ¹æ¹ý ±èż®(°¿øÀÇ´ë)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:00~13:30 Á¤»ó °£ÃÊÀ½ÆÄ ½ºÄµ ¼ºÇʼö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:30~14:00 Á¤»ó Ãé´ãµµ ÃÊÀ½ÆÄ ½ºÄµ °¹Î±Ô(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:00~14:30 °£Áúȯ ¹× Á¾±« ÃÊÀ½ÆÄ ½ºÄµ ÀÌÀ¯¸²(°æºÏÀÇ´ë)